Aleafia Health’s (ALEF.C) subsidiary, Emblem Cannabis, has signed a licensing agreement with Kinstate Inc, to bring Kin’s sublingual cannabis strips brand and tech to the Canadian medical and adult-use market.
Chemesis International (CSI.C) is backing off the vape train and offering a safer, more familiar alternative in these trying times: hemp cigarettes.
Chemesis International (CSI.C) subsidiary Natural Ventures vertical grow doubles output to meet demand
Chemesis International’s (CSI.C) installation of VividGro LED lighting and environment controls in their Natural Ventures cultivation facility takes a serious step towards solving the chronic shortage of cannabis in Puerto Rico.
Chemesis International (CSI.C) closed its all-shares deal to acquire controlling interest in Puerto Rico based GSRX Industries today.
Two days ago, Zenabis Global (ZENA.T) formed an agreement with a Canadian beverage company, which will supply them the inputs required for Zenabis to enter into the edibles market in October.
Chemesis International (CSI.C) expanded its global footprint on Monday by announcing a new U.K. purchase order for its CBD products.
Chemesis International (CSI.C) has signed letters of intent (LOIs) with 34 private liquor stores in British Columbia to distribute their hemp-based chew products.
On August 12, 2019 Chemesis International (CSI.C) announced that it will start manufacturing, packaging and distributing its own line of tobacco-free smokeless cannabis and hemp-derived chew in Puerto Rico and Canada and the U.S.
Ichiro Suzuki – a recently retired major league baseball player – hit only 117 home runs in 9,934 career at bats. That’s a 1.2% home run success ratio. Yet Suzuki is considered one of the most effective batters ever to play the game.
Reading Chemesis International’s (CSI.C)‘s July 26, 2019 “operational and corporate update” is like watching footage of a toddler vacuuming a living room.